Quercetin improves hepatic fibrosis reducing hepatic stellate cells and regulating pro-fibrogenic/anti-fibrogenic molecules balance

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 12, 2012, Pages 1865-1872

  Hernández Ortega, Luis Daniel ^a   Alcántar Díaz, Blanca Estela ^b   Ruiz Corro, Luis Alberto ^a   Sandoval Rodriguez, Ana ^a   Bueno Topete, Miriam ^a   Armendariz Borunda, Juan ^a   Salazar Montes, Adriana María ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NAYARIT   (Mexico)

Author keywords

Anti inflammatory properties; Hepatic fibrosis; Hepatic stellate cells; Quercetin

Indexed keywords

CATALASE; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER ENZYME; QUERCETIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROGENESIS; GENE EXPRESSION; LIVER FIBROSIS; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; STELLATE CELL;

ANIMALS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HEPATIC STELLATE CELLS; INFLAMMATION; LIVER CIRRHOSIS; MALE; METALLOPROTEASES; OXIDATIVE STRESS; QUERCETIN; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84869784553     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07262.x     Document Type: Article

References (34)

1. Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci. 2004; 96: 229-245.
2. Korkina LG, Afanas'ev LB. Antioxidant and chelating properties of flavonoids. Adv. Pharmacol. 1997; 38: 151-163.
3. Scalbert A, Johnson LT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am. J. Clin. Nutr. 2005; 81: 215S-217.
4. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Eur. J. Clin. Nutr. 1996; 50: 63-71.
5. Gupta M, Mazumder UK, Sambath KR. Antioxidant and protective effect of Ervatamia coronaria Stapf leaves against carbon tetrachloride induced liver injury. Eur. Bull. Drug Res. 2004; 12: 13-22.
6. Kukongviriyapan V, Janyacharoen I, Kukongviriyapan U, Laupattarakasaem P, Kanokmedhakul S, Chantaranothai P. Hepatoprotective and antioxidant activities of tetraceraloureiri. Phytother. Res. 2003; 17: 717-721.
7. Huk I, Brovkovych V, Nanobash Vili J etal. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br. J. Surg. 1998; 85: 1080-1085.
8. Boots AW, Li H, Schins RP etal. The quercetin paradox. Toxicol. Appl. Pharmacol. 2007; 222: 89-96.
9. Yang K, Lamprecht SA, Liu Y etal. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 2000; 21: 1655-1660.
10. Igura K, Ohta T, Kuroda Y, Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 2001; 171: 11-16.
11. Wu LC, Lu IW, Chung CF, Wu HY, Liu YT. Antiproliferative mechanisms of quercetin in rat activated hepatic stellate cells. Food Funct 2011; 2: 204-212.
12. Walker EH, Pacold ME, Perisic O etal. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine. Mol. Cell 2000; 6: 909-919.
13. Madhavan PN, Mahajan S, Reynolds JJ etal. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-κB system. Clin. Vaccine Immunol. 2006; 13: 319-328.
14. Peres W, Tuñon MJ, Mato S, Collado PS, Marroni N, Gonzalez-Gallego J. Hepatoprotective effects of the flavonoid quercetin in rats with biliary obstruction. J. Hepatol. 2000; 33: 742-750.
15. Pavanato A, Tuñon MJ, Sanchez-Campos S etal. Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis. Dig. Dis. Sci. 2003; 48: 824-829.
16. Salazar-Montes A, Ruiz-Corro L, López-Reyes A, Castrejón-Gómez E, Armendáriz-Borunda J. Potent antioxidant role of Pirfenidone in experimental cirrhosis. Eur. J. Pharmacol. 2008; 595: 69-77.
17. Salgado S, García J, Vera J etal. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol. Ther. 2000; 2: 545-551.
18. Chomzynsky P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-cloroform extraction. Anal. Biochem. 1987; 162: 156-159.
19. User Bulletin #02 ABI PRISM 7700 Sequence Detection System December 11, 1997. Cited Jan 2012. Available from URL: http://dna-9.int-med.uiowa.edu/RealtimePCRdocs/Bulletin%202%20Applied%20Byosistem.
20. Misra HP, Fridovich I. Superoxide dismutase and peroxidase: a positive activity stain applicable of polyacrylamide gel electropherograms. Arch. Biochem. Biophys. 1977; 183: 511-515.
21. Manchenko GP. Handbook of Detection of Enzymes on Electrophoretic Gels. Boca Raton: CRC Press, 1994; 92.
22. Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem. J. 1994; 304: 817-824.
23. Kleiner DE, Stetler-stevenson WG. Quantitative zymography: detection of pictogram quantities of gelatinases. Anal. Biochem. 1994; 218: 325-329.
24. Comalada MD, Camuesco D, Sierra S etal. In vivo quercetin anti-inflammatory effect involves release of quercetin wich inhibits inflammation through down-regulation of the NF-kB pathway. Eur. J. Immunol. 2005; 35: 584-592.
25. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000; 52: 673-751.
26. Bors W, Michel C, Saran M. Flavonoid antioxidants: rate constants for reactions with oxygen radicals. Methods Enzymol. 1994; 234: 420-429.
27. Noroozi M, Angerson W, Lean ME. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr. 1998; 67: 1210-1218.
28. Afanas'ev IB, Dorozhko AI, Brodskii AV, Kostyuk VA, Potapovich AI. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 1989; 38: 1763-1769.
29. Weiler-Normann C, Herkel J, Lohse AW. Mouse model of liver fibrosis. Z. Gastroenterol. 2007; 45: 43-50.
30. Recknagaci R. Carbon tetrachloride hepatotoxicity. Pharmacol. Rev. 1967; 19: 145-196.
31. Bear WL, Teel RW. Effects of citrus phytochemicals on liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK. Anticancer Res. 2000; 20: 3323-3329.
32. Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants resveratrol, quercetin and N-Acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells. Hepatology 1998; 27: 1265-1274.
33. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669.
34. Mrowietz U, Seifert O. Keloid scarring: new treatments ahead. Actas Dermosifiliogr 2009; 100 (Suppl. 2): 75-83.